FDA's Voice of the Patient Report on Chronic Fatigue Syndrome Reveals Disease Impact and Areas for Progress

FDA's Voice of the Patient Report on Chronic Fatigue Syndrome Reveals Disease Impact and Areas for Progress
http://www.sacbee.com/2013/10/03/5791682/fdas-voice-of-the-patient-report.html

"GRAND RAPIDS, Mich., Oct. 3, 2013 /PRNewswire-USNewswire/ -- PANDORA Org and other patient organizations say a recent report from the U.S. Food and Drug Administration (FDA) shows the agency must take further action to open up opportunities for ME/CFS drug development. Titled "The Voice of the Patient," this report is a detailed summary of an April 25 FDA Patient-Focused Drug Development meeting, the first of its kind, where patients explained the reality of Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS). "